Purpose : This longitudinal study aimed to compare ovarian perifollicular and endometrial blood flow (PFBF and EBF, respectively) during the follicular phase in pregnant and nonpregnant IVF cycles. Methods : Serial transvaginal scans were performed in 15 subjects undergoing IVF treatment. Both PFBF and EBF were subjectively graded (grades 0-4 for PFBF and grades 1-3 for EBF). After confirmation of clinical pregnancy, the treatment cycles were grouped into 'Pregnant' and 'Non-pregnant' cycles. Ovarian PFBF and EBF were retrospectively compared between the two groups. Results : In pregnant cycles, the proportion of large (≥15 mm) follicles with high (2-4) grade PFBF increased with time throughout the follicular phase, and the proportion of large follicles with poor (0-1) grade PFBF decreased. In non-pregnant cycles these trends were reversed. There was no difference in EBF between the two groups. Conclusion : The pattern of ovarian PFBF but not EBF may be predictive of treatment outcome.
INTRODUCTION
Fifteen percent of couples worldwide experience either primary or secondary infertility (1) . Assisted reproduction technologies (ART), such as controlled ovarian hyperstimulation and In vitro Fertilisation (IVF), are helping many infertile couples to become parents (2) .
Numerous ovarian stimulation protocols have been used in ART, and they have been continuously modified with an aim to improve the ART outcomes. In most of these stimulation protocols, Gonadotropin releasing hormone (GnRH) agonist is used to reversibly block the pituitary function and prevent a luteinising hormone surge. In short and ultrashort protocols, gonadotropins are administered 2 or 3 days after the start of GnRH agonist, whereas long down-regulation protocol involves the use of GnRH agonist for 2-3 weeks to desensitize the pituitary prior to the administration of gonadotropins (3) .
One of the most common stimulation protocols is the long down-regulation protocol. A meta-analysis of 26 trials on long, short and ultrashort protocols has shown that the odds ratio for clinical pregnancy per cycle started was 1.32 (95% CI, 1.10-1.57) in favour of the long down-regulation protocol over the other protocols (3) . However, on an average only a 24.7% clinical pregnancy rate per aspiration for IVF and 26% for Intracytoplasmic sperm injection (ICSI) was achieved (4) .
Poor embryo quality and poor endometrial receptivity are suggested to be the major causes of failure in infertility treatment. One of the factors associated with poor embryo quality and low-pregnancy rate in IVF is poor follicular vascularity assessed by colour Doppler ultrasound (CDU) or power Doppler ultrasound (PDU) on the day of egg collection (5) (6) (7) (8) .
Similarly, poor endometrial receptivity is associated with poor blood flow through the endometrium assessed either on the day of hCG trigger (9, 10) , day of oocyte collection (11) or day of embryo transfer (12) . However, Contart et al. (13) demonstrated that there was no difference in endometrial blood flow on the day of hCG administration between pregnant and non-pregnant cycles in IVF, conflicting with the findings described earlier. Hence, the predictive value of endometrial blood flow (EBF) for cycle outcome in IVF is still controversial. Either CDU or PDU was used to measure blood flow through the endometrium in these cross-sectional studies.
There are no published longitudinal studies assessing ovarian follicular or endometrial blood flow. This is the first longitudinal study assessing ovarian PFBF and EBF using PDU in the IVF setting. We aimed to compare the patterns of ovarian PFBF and the EBF over the follicular phase between pregnant and nonpregnant treatment cycles. In the IVF long down-regulation protocol, patients were pre-treated with the oral contraceptive pill (OCP) (Brevinor 21, Pharmacia Australia, Rydalmere, NSW, Australia) from day 5 of the menstrual cycle preceding the treatment cycle for 21 days. Fifteen days after starting the OCP, GnRH agonist was introduced, either as a nasal spray (Nafarelin acetate, Pharmacia Australia, Rydalmore, NSW, Australia) 200 µg twice daily, or as subcutaneous injections (Leuprorelin acetate, Abbott Australasia, Cronulla, NSW, Australia) 1 mg daily for at least 10 days until pituitary downregulation was confirmed (serum estradiol <120 pmol/L). Recombinant follicle stimulating hormone injections (Gonal F, Serono Laboratories, Frenchs Forest, NSW, Australia or Puregon, Organon Laboratories, Lane Cove, NSW, Australia) for ovarian stimulation were then commenced, with the starting dose being determined according to the patients age and the presence or absence of polycystic ovaries (PCO) on ultrasound. Daily FSH injections and GnRH agonist were continued until the day of human chorionic gonadotropin (hCG) injection (Profasi, Serono Laboratories, Frenchs Forest, NSW, Australia).
MATERIALS AND METHODS

This
An intramuscular trigger injection of hCG 10,000 i.u. was given when at least one follicle was ≥18 mm in mean diameter. Transvaginal sonography (TVS) guided ovum pick up was performed 36 h after the hCG injection. The eggs collected were either inseminated (IVF) or injected (ICSI) with prepared sperm 2 to 4 h following collection, and fertilisation was confirmed 16 to 18 h later. Embryos were transferred transcervically into the uterine cavity under ultrasound control 2 or 3 days following ovum pick up. Clinical pregnancy was confirmed by the visualisation of a gestational sac on ultrasound at week 6 of amenorrhoea.
All subjects underwent serial transvaginal Doppler ultrasound scanning using an Eccocee SSA -340A ultrasound machine (Toshiba Corporation, Japan) with power and colour Doppler facilities, equipped with a 6 MHz curvilinear transvaginal probe. The spatial peak temporal average intensity of ultrasound for B-mode and Doppler examinations was less than 100 mW/cm 2 , which is within the safety limits recommended by the Bioeffects Committee of the American Institute of Ultrasound in Medicine (14) . The sensitivity for the detection of blood flow was set at 0.09 cm/s for all the cases. During power Doppler ultrasound colour gain for all the cases was set at the level A3 (10) , where A stands for amplitude and A3 denotes highest amount of persistence, 10 shows the level of colour gain when the noise (over-gaining) just disappears. All scans were performed by a single operator (SMS) at the same time each morning (between 7 am and 9.30 am), thus controlling the effects of circadian variation in blood flow (15) . The first transvaginal scan (TVS) was performed on the day of down-regulation check, and the second was on day 6 of FSH injections for all the subjects. Thereafter TVS was performed every 2 or 3 days until the day of hCG administration.
During the ultrasound scanning of each ovary, the power Doppler colour box was positioned over each ovarian follicle and the cross-sectional image of the follicle with the maximum colour indication in the follicular circumference was frozen and then the PFBF was graded. Ovarian PFBF was graded using a modified grading system (Grade 0: 0%, Grade 1: 1-25%, Grade 2: 26-50%, Grade 3: 51-75%, Grade 4: 76-100%) based on that of Chui et al. (5) . Briefly, Grade 0 follicles do not have any detectable blood flow around the follicular circumference, Grade 1 follicles have blood flow visible in 1 to 25% of the follicular circumference; Grade 2 follicles have blood flow visible in 26 to 50% of the follicular circumference, Grade 3 follicles have blood flow visible in 51 to 75% of the follicular circumference, and Grade 4 follicles have blood flow visible in 76 to 100% of the follicular circumference. Thereafter, the size of the follicle was calculated from the mean of two maximum diameters. The study follicles were also divided into one of three categories according to the size range: small (5-10 mm), medium (11-14 mm) and large (≥15 mm). Similarly, the PFBF grade of all follicles was also categorized into high grade (Grades 2-4) or poor grade (Grades 0-1).
To measure EBF, the colour box was placed over the entire length of endometrium in the longitudinal plane and the endometrial blood flow was subjectively graded as Grade 1, 2 or 3. Grade 1 EBF was when there were no penetrating vessels in the junction between the myometrium and the endometrium, or from the outer hyperechogenic line in the triple line endometrium, Grade 2 EBF was when there was the presence of some penetrating vessels but no detectable flow through the endometrium itself and Grade 3 EBF was when there was some detectable intra-endometrial blood flow. This grading system was developed conjointly by two of the authors (SMS, GM) for this study. Endometrial thickness was also measured on each ultrasound assessment day. The longitudinal section of the uterus with the best image of endometrium in real time B-mode ultrasound was frozen and the endometrial thickness (mm) was measured as the maximum distance between each myometrial/endometrial interface through the central longitudinal axis of the uterus.
When assessment for clinical pregnancy had been completed for all subjects, the treatment cycles were divided into two groups: 'Pregnant' and 'Non-pregnant.' Ovarian PFBF and endometrial blood flow during the entire follicular phase was analysed retrospectively in the two groups. The assessment days for TVS were not identical for each subject, except for the day of down-regulation assessment and day 6 of stimulation. Therefore, these other assessment days were grouped as days 8 to 9, days 10 to 11, days 12 to 13 and days 14 to 15. Each subject had only one TVS assessment on any grouped days (i.e. one TVS assessment on either day 8 or 9, one TVS assessment on either day 10 or 11, etc.).
Statistical Analysis
The data was tested for normal distribution using the Kolmogorov-Smirnov (K-S) test. Continuous variables were analysed using either the unpaired Student's t-test (normal data distribution) or the Mann-Whitney U test (skewed data) to compare means or medians where appropriate. Categorical variables were analysed using the Chi-square (χ 2 ) or Fishers Exact Test where appropriate. The leastsquares method was used to plot the trend line for line of best fit. Either Paired Sample t-test (for endometrial thickness) or Wilcoxon Signed Ranks Test (for ovarian PFBF and endometrial blood flow grading) was used to assess the intra-observer variability. A p value <0.05 was considered statistically significant. Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) version 11.0.
RESULTS
A total of 15 patients undergoing 15 cycles of the IVF long down-regulation protocol were studied. There were eight (53%) pregnant cycles and seven (47%) non-pregnant cycles.
The demographic and clinical data for pregnant and non-pregnant treatment cycles are seen in Table I . There were no significant differences between the two groups in terms of age, body mass index (BMI), duration of infertility, type of infertility, cause of infertility, parity, presence of polycystic ovaries on ultrasound (PCO), smoking, serum level of estradiol on the last scan day, in the day of hCG trigger, number of eggs retrieved, number of eggs fertilized and number of embryos transferred or frozen. However, there was a tendency for the trigger day to be earlier in the nonpregnant group. Table II demonstrates the number of large follicles with high and poor grade PFBF in the two types of treatment cycles. There were no significant differences in the proportion of large follicles with high-and poor-grade PFBF between pregnant and non-pregnant treatment cycles on any of the days of the follicular phase. However, in cycles resulting in pregnancy there was an upward trend for the proportion of large follicles with high-grade PFBF as one progressed throughout the follicular phase, whereas there was a downward trend for the proportion of large follicles with poor grade PFBF. In cycles not resulting in pregnancy these relationships were reversed ( Figs. 1 and 2) . It was not possible to statistically compare these trend lines as it is not valid to perform regression analysis on the basis of only four-point observations over time. Table III demonstrates the number of patients with different grade endometrial blood flow in pregnant and non-pregnant cycles during the follicular phase. There was no significant difference in endometrial blood flow between these two groups. However, the disappearance of Grade 1 endometrial blood flow in pregnant cycles occurred earlier compared to nonpregnant cycles.
Reliability Assessment
For intra-observer error, there was no significant difference between the consecutively repeated measurements of endometrial thickness (Paired Sample t-test p > 0.05), ovarian PFBF and endometrial blood flow (Wilcoxon Signed Ranks Test p > 0.05). In addition, there was no inter-observer variability in this study because all the measurements were performed by the same operator (SMS).
DISCUSSION
This is the first longitudinal study comparing ovarian perifollicular vascularity and the endometrial vas- a Day of downregulation check. b Grade 1 endometrial blood flow = when there are no penetrating vessels in the junction between the myometrium and the endometrium, or from the outer hyperechogenic line in the triple line endometrium. c Grade 2 endometrial blood flow = when there is a presence of some penetrating vessels but no flow through the endometrium itself. d Grade 3 endometrial blood flow = when there is some detectable intra-endometrial blood flow. e Number (%) n = Number of cycles; NA = not applicable. cularity semi-quantitatively between pregnant and non-pregnant treatment cycles in women undergoing IVF. This present study demonstrated that in cycles resulting in pregnancy, there was an upward trend in the proportion of large follicles with high-grade PFBF as one progressed along the follicular phase compared to a corresponding downward trend in the proportion of large follicles with poor grade PFBF. In cycles not resulting in pregnancy these relationships were reversed. Therefore, there tends to be an inverse relationship in the proportion of large follicles with high-and poor-grade PFBF between pregnant and non-pregnant cycles from the time of their first appearance until the day of hCG trigger. However, the endometrial blood flow did not differ between these two types of cycles.
Power Doppler ultrasound was used to assess the ovarian perifollicular and endometrial vascularity, because it is the most sensitive mode of Doppler ultrasound for semi-quantitative measurement of blood flow (16, 17) . In comparison to PDU, assessment of vascularity using colour Doppler ultrasound (CDU) has limitations due to its lower signal-to-noise ratio. Moreover, it is prone to aliasing and it is angle dependent (16, 17) .
There have been four studies published assessing ovarian PFBF in patients undergoing IVF treatment, three of which used PDU (5-7) and one using CDU (8) . These studies were all cross-sectional studies, with ovarian PFBF being assessed on the day of, but prior to, hCG administration in the CDU study, and on the day of oocyte retrieval in the PDU studies. All studies used the same grading system (grades 1 to 4) for PFBF grade, and all four individual studies showed a significant improvement in cycle pregnancy rate (CPR) if embryos resulting from the fertilization of eggs from follicles with higher-grade PFBF were used. In addition, a recent meta-analysis of the three PDU studies confirmed an almost five-fold improvement in CPR if embryos transferred during IVF resulted from the fertilization of eggs from the follicles with better PFBF (18) , demonstrating that ovarian PFBF in the latefollicular phase is a predictor of treatment outcome.
It is important to note that the grading of ovarian PFBF and the categorization of high-grade and low/poor-grade PFBF in our study is different to the published three PDU studies (5-7). In these studies, ovarian follicles were graded from grades 1 to 4, whereas in our study we graded follicles from Grades 0 to 4. The minor difference was due to follicles with 0-25% PFBF being categorized as Grade 1 in the earlier studies, whereas in the present study follicles with 0% PFBF were categorized as Grade 0 and follicles with 1-25% PFBF were categorized as Grade 1. Perifollicular blood flow grades 2, 3, and 4 were identical between the earlier studies and our study.
A further difference between our study and the other PDU studies (5-7) is the classification of high (Grades '2 to 4' and '3 to 4,' respectively) and low/poor (Grades '0 to 1' and '1 to 2,' respectively) grade ovarian PFBF. In addition, the proportion of Grade 3 and 4 follicles was higher in the studies by Chui et al. (5) (52%) and Bhal et al. (6) (64%) than observed in our study. The information on the proportion of Grade 3 and 4 follicles was not available in the PDU study by Borini et al. (7) . The proportion of Grade 3 and 4 follicles in our study ranged between 1 and 2% in small sized follicles, 5-6% in medium sized follicles and 2-14% in the large sized follicles throughout the follicular phase.
The most likely explanation for this difference in the proportion of Grade 3 and 4 follicles between the present study and the other studies is the difference in timing of the TVS assessments relative to the timing of the hCG trigger injection. Exogenous hCG or endogenous LH surge has been demonstrated to increase angiogenesis of human ovarian follicles by increasing local vascular endothelial growth factor (angiogenic factor) production (17) . The ovarian PFBF in the above cited studies (5-7) was assessed on the day of egg pick up (approximately 32-34 h following hCG administration) compared to all PFBF assessments being performed prior to the hCG trigger in our study.
The mechanism underlying the link between follicular vascularity and implantation outcome remains unclear at present. However, possibilities include a link between ovarian follicular blood flow and oocyte quality. An association between poor follicular vascularity and aneuploidy has been observed by a number of authors (5, 6, 20) . Subsequently, Van Blerkom et al. (21) demonstrated that oocytes derived from follicles with low oxygen content have a significantly higher frequency of defects in chromosome number, spindle organization, and cytoplasmic structure as well as a significantly reduced ability to develop to the 6-8 cell stage embryo in vitro when fertilized. Such a hypoxic intrafollicular environment could result from a failure of an appropriate microvasculature to develop around the growing follicle.
We are unaware of any previously published longitudinal studies assessing ovarian PFBF throughout the entire follicular phase either in the natural menstrual cycle or in the IVF setting. Understanding the dynamics of the ovarian perifollicular blood flow in pregnant and non-pregnant cycles throughout the follicular phase might aid in determining both the role and predictive value of ovarian PFBF in the outcome of IVF treatment earlier in the cycle rather than in the later stage of the treatment cycle.
The uncertain role of uterine artery impedance measured either on the day of hCG administration (22) (23) (24) , on the day of egg pick-up (5, 6, 25) , or on the day of embryo transfer (26) generated the idea that the quality of endometrium may be more important than the global blood flow throughout the entire uterus. As a result of this, a number of studies were conducted in stimulated intrauterine insemination programmes determining the predictive value of spiral artery (the main branch of uterine artery to the endometrium) impedance for the outcome of the treatment (27, 28) . None of these studies demonstrated a significant difference in endometrial blood flow between pregnant and non-pregnant treatment cycles.
However, in the IVF setting Kupesic et al. (29) demonstrated that the PI of subendometrial vessels was significantly lower in a pregnant group compared to a non-pregnant group. Interestingly, Zaidi et al. (9) determined the presence or absence of sub and intraendometrial vascularisation on the day of hCG trigger, and reported that there were no pregnancies when there was no detectable sub or intraendometrial blood flow. In our study, there were no cycles (either pregnant or non-pregnant) with grade 1 EBF (i.e. without sub-or intra-endometrial vascularisation) from cycle day 6 onwards (data not shown).
In a number of studies, endometrial blood flow has been subjectively assessed using either CDU (10, 12) or PDU (11, 13) and correlated with the outcome of IVF treatment. These studies were cross-sectional, with endometrial blood flow being assessed on the day of, but before, hCG administration (10, 13) , on the day of oocyte retrieval (11) or on the day of embryo transfer (12) . These studies assessed the endometrial blood flow subjectively using different grading systems and all showed that better blood flow through the endometrium is associated with a higher clinical pregnancy rate except that of Contart et al. (13) .
Coulam et al. (10) studied 116 women undergoing IVF and graded the endometrial blood flow on the day of, but before, hCG administration as Grade 1 (when blood flow was recorded in the myometrium less than half way to the centre), Grade 2 (when blood flow was recorded in the myometrium equal to or greater than half way to the centre), Grade 3 (when blood flow is recorded in the subendometrial space) and Grade 4 (when the blood flow is recorded inside the endometrium). These investigators demonstrated that all the pregnancies occurred in women with Grade 3 and 4 endometrium. Grades 3 and 4 endometrial blood flow in the study by Coulam et al. (10) would correspond to Grade 2 and 3 endometrial blood flow respectively in our study. Our data showed that nine patients had their endometrial blood flow assessed on the actual day of, but prior to hCG trigger. Four of these nine patients conceived and all four of these pregnant patients had grade 2 or 3 endometrial blood flow (data not shown). Therefore, our findings are consistent with these of Coulam et al. (10) .
Later, Chien et al. (12) studied 623 women undergoing IVF on the day of embryo transfer and the endometrial blood flow was divided into three groups (A, B, C) using the scoring system of Applebaum (30), with Group A representing patients with no detectable endometrial or subendometrial blood flow, Group B representing patients with presence of only subendometrial blood flow, and Group C representing patients with presence of sub-and intra-endometrial blood flow. These authors reported that the pregnancy rates in these three groups of patients were significantly different with Group C having the highest pregnancy rate and group A the lowest. Similarly, the miscarriage rate in Group A was significantly higher compared to Group B or C. Groups A, B and C in the study by Chien et al. corresponded with endometrial blood flow grades 1, 2 and 3, respectively in our study.
Yang et al. (11) studying 95 women undergoing IVF treatment reported that women with an intraendometrial power Doppler area (EPDA) ≥5 mm 2 achieved a significantly higher pregnancy rate (47.5% vs. 23.5%, p = 0.021) compared to those with an EPDA <5 mm 2 . EPDA was defined as an area (mm 2 ) of vascular signals within the endometrialmyometrial interface.
In contrast, Contart et al. (13) evaluated endometrial vascularisation in 185 patients undergoing ICSI and reported that there was no significant difference in pregnancy and implantation rate in women with different grades of endometrial vascularity, with grades being determined by visualisation of PDU signal (PDS) in the four quadrants of the image of the uterus, regardless of the amount of colour in the quadrant (Grade 1 = PDS in one quadrant, Grade 2 = PDS in two quadrants, Grade 3 = PDS in three quadrants, Grade 4 = PDS in four quadrants).
Thus, the predictive value of endometrial vascularity for treatment outcome is still undecided although three of four studies found that better endometrial blood flow was associated with a higher pregnancy rate. Only two of the four cited studies used PDU, the most sensitive mode of Doppler ultrasound in visualisation of microvasculature (17) . One PDU study demonstrated better endometrial vascularity to be a predictor of better endometrial receptivity (11) , and the other PDU study showed no difference (13) . The present PDU study also failed to demonstrate a significant difference between pregnant and non-pregnant treatment cycles in the endometrial blood flow at any stage of the follicular phase.
Our findings suggest that follicular phase ovarian PFBF (possibly reflecting oocyte quality) may be a better predictor of treatment outcome than follicular phase endometrial blood flow (possibly reflecting endometrial quality) in IVF. This is not surprising given that the maximum serum estradiol level and endometrial thickness did not differ between pregnant and non-pregnant cycles (Table I) . Serum estradiol concentrations have been demonstrated to correlate with both better blood flow through the endometrium and thicker endometrium (31, 32) .
There are several limitations to this study. Firstly, this pilot study was performed without using power calculations to determine an adequate sample size. Sample size calculation was not possible, as no prior longitudinal data has been published on ovarian PFBF throughout the follicular phase of IVF treatment cycles on which to base such calculations. It is most likely that the lack of a statistically significant difference between the proportion of large follicles with high-grade PFBF on any given cycle day between pregnant and non-pregnant cycles was due to a lack of study power (type two error) due to the small sample size. However, there was a trend towards an initially lower followed by a later higher proportion of high-grade ovarian PFBF in pregnant cycles compared with non-pregnant cycles as IVF ovarian stimulation progressed.
Secondly, it would have been preferable if the TVS examinations had been performed on the same cycle days for all patients (i.e. cycle day 9 rather than day 8 or 9 etc.) but this was not possible due to logistical reasons.
We intend to embark on a larger retrospective cohort study (the ideal study design for such a study given that one cannot assign cycles prospectively as being pregnant or non-pregnant) to confirm the findings of this pilot study.
CONCLUSION
The longitudinal pattern of ovarian PFBF in pregnant cycles is different to that of non-pregnant cycles. There was no difference in the endometrial vascularity between pregnant and non-pregnant cycles. The pattern of blood flow through the ovarian follicles may be more predictive of treatment outcome than endometrial blood flow.
